Q&A: Thermoformer Talks Basics of Sustainability in Healthcare Packaging, PCR

Says corporate sustainability manager Zach Muscato: ‘…traditionally, the industry has almost over-engineered packages to reduce risk, and they're realizing now that that's no longer acceptable because that can lead to unnecessary waste.’

'From a healthcare perspective, the focus is on a package’s end-of-life improvement, particularly for applications that are used in a clinical setting like a hospital,' says Plastic Ingenuity's Zach Muscato.(Photo credit: Plastic Ingenuity)
'From a healthcare perspective, the focus is on a package’s end-of-life improvement, particularly for applications that are used in a clinical setting like a hospital,' says Plastic Ingenuity's Zach Muscato.(Photo credit: Plastic Ingenuity)

In any packaging conversation, "sustainability" is bound to come up, but the topic means different things to different stakeholders. At PACK EXPO International, we talked with Zach Muscato, corporate sustainability manager at Plastic Ingenuity, who has 20 years of experience in the thermoformed packaging industry, about what he’s seeing across healthcare and food packaging.

Healthcare Packaging (HCP): Life science brand owners are typically slow to adopt packaging changes due to patient safety priorities and regulatory activities. As your customers in life sciences tackle their sustainability improvements, where are you seeing broad focus?

Zach Muscato (ZM): From a healthcare perspective, the focus is on a package’s end-of-life improvement, particularly for applications that are used in a clinical setting like a hospital. Nearly all of those materials today are incinerated or go to landfill. That’s not acceptable, so you have nonprofits like Practice Greenhealth and group purchasing organizations that are really driving the conversation forward by saying, ‘Look, we need better end of life solutions in place.’ Easier said than done of course.

It feels like people are finally a little more open to trying to change. Maybe that’s my perspective, seeing them when they’re ready for a change. I would say some organizations are prioritizing this, trying to be thought leaders, and those are the ones that we really want to work with.

HCP: Can you give a brief overview on the landscape of recycling healthcare packaging?

ZM: There are a lot of barriers to recycling in healthcare facilities. That’s where there’s a lot of interest, figuring out how we get to a system where these packages are recovered in a healthcare setting, because they’re highly valuable and they’re typically all virgin material.

Plus, there’s not enough PCR from other sources to go around right now. It’s in huge demand for all industries. So, there’s a lot of focus on collection, and then that’s where advanced recycling plays a really key role—processing a mix of materials that’s really unique. MDMs are trying to figure out the best way to use that now that it’s emerging. It’s going to be interesting to see how all these materials get collected, aggregated, and sorted and transported at whatever volume it is to the facility.

HCP: What have your customers been seeking lately?

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report